INS webinars deliver the most current infusion-related topics in a 60-minute presenter-led session. Each webinar is delivered live and then archived for on-demand viewing. All webinars are free to INS members.

Webinars

  • Challenges and Management of Infusion Reactions in Inflammatory Bowel Disease (IBD)

    Contains 3 Component(s), Includes Credits Includes a Live Event on 09/18/2019 at 4:00 PM (EDT)

    Inflammatory Bowel Disease (IBD), comprised of ulcerative colitis and Crohn’s disease, is a chronic disease influenced by the interaction of the environment, immune system, genetics, and gut microbiota. Currently 1.6 million Americans and 5 million people worldwide are affected by the unpredictable and challenging disease management of IBD. A complete understanding of IBD pathogenesis is unknown and there is no standardized treatment for IBD. Medication therapy options may include biologics, antibiotics, immunomodulators, corticosteroids, and aminosalicylates, requiring the infusion nurse to remain current with evidence-based practice. Listen to this webinar presentation, which focuses on the role of the infusion nurse, to learn more about challenges and developments in the management of IBD.

    Commercial Support: Takeda

    image

    Inflammatory Bowel Disease (IBD), comprised of ulcerative colitis and Crohn’s disease, is a chronic disease influenced by the interaction of the environment, immune system, genetics, and gut microbiota. Currently 1.6 million Americans and 5 million people worldwide are affected by the unpredictable and challenging disease management of IBD. A complete understanding of IBD pathogenesis is unknown and there is no standardized treatment for IBD. Medication therapy options may include biologics, antibiotics, immunomodulators, corticosteroids, and aminosalicylates, requiring the infusion nurse to remain current with evidence-based practice. Listen to this webinar presentation, which focuses on the role of the infusion nurse, to learn more about challenges and developments in the management of IBD.  

    Learning Outcomes: At the conclusion of this webinar, the learners will be able to: 
    1) Discuss the pathogenesis of IBD and the current treatment options available for patients with IBD 
    2) Identify challenges and ways to manage these challenges when administering infusion medications to patients with IBD

    Rashmi Kumar, MD

    Gastroenterologist, Banner University Medical Center- Phoenix

    Rashmi Kumar, MD is a gastroenterologist at Banner University Medical Center- Phoenix. She finished medical school in India, having graduated fourth in her class, from Patna Medical College, Bihar. Her journey continued with an internal medicine residency at St. Joseph's Hospital and Medical Center, Phoenix. For further training in gastroenterology, she joined the University of Arizona College of Medicine- Phoenix and successfully earned her degree in 2018. Dr. Kumar is particularly focused on inflammatory bowel disease. 

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 18, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • Intravenous Push Medication Safety: Reducing the Risk for Patient Harm

    Contains 3 Component(s), Includes Credits Recorded On: 08/29/2019

    Infusion therapy is commonplace in many clinical settings, as is the administration of intravenous (IV) push medications. It is essential for nurses to have the knowledge to correctly administer IV push medications and manage the associated challenges. This presentation will examine current evidence-based practice, identify potential risks for errors and complications, and make recommendations for safer practices associated with IV push medication administration.

    Commercial support: Fresenius Kabi

    image


    Infusion therapy is commonplace in many clinical settings, as is the administration of intravenous (IV) push medications. It is essential for nurses to have the knowledge to correctly administer IV push medications and manage the associated challenges. This presentation will examine current evidence-based practice, identify potential risks for errors and complications, and make recommendations for safer practices associated with IV push medication administration.

    Learning Outcomes: At the end of this program, the learner will be able to:
    • Discuss challenges associated with intravenous push medications.
    • Examine current evidence and practice related to intravenous push medication safety.
    • Identify potential risks and complications related to intravenous push medication.
    • Describe best practice for safe IV push medication administration.

    Candy Cross, MSN-Ed, RN

    Adjunct instructor, Chandler-Gilbert Community College

    Candy Cross, MSN-Ed, RN, is an adjunct instructor for Chandler-Gilbert Community College. For the past 5 years she served as the new grad/simulation manager for Dignity Health East Valley, assisting new graduate RNs transition to practice. Prior to that role, she worked in the CVICU for 12 years at a cardiac hospital and 6 years as a clinical education specialist. Candy earned her bachelor’s degree in 2007 from the University of Phoenix and her MSN-Ed from Grand Canyon University in 2011.

    Denise Dion, MSN-Ed, RN, PCCN, CNE

    Nurse Educator, Central Arizona College

    Denise Dion, MSN-Ed, RN, PCCN, CNE, is a nurse educator at Central Arizona College. She has 27 years of experience as a nurse, with the majority of her career spent in cardiac care. She earned her BSN from University of Massachusetts-Boston and an MSN-Ed from the University of Phoenix.  Denise has been working closely with colleagues to bring IV push medication best practice to bedside nurses and nurse faculty throughout Arizona.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 29, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • Immune Thrombocytopenia: Waiting for the Other Shoe to Drop

    Contains 3 Component(s), Includes Credits Recorded On: 08/14/2019

    Immune thrombocytopenia (ITP) is an autoimmune disease that attacks the body’s platelets. It can have a newly diagnosed and persistent component and can occur in both children and adults. This presentation will discuss newly diagnosed and persistent ITP, diagnosis and treatment for children and adults, and long-term effects for patients with persistent ITP, including psychosocial and financial issues. A case example will follow a patient from diagnosis through various treatments over a 20-year span. At the conclusion of this presentation, the infusion nurse should be able to understand the importance of his or her role in administering IV medications as well as how their interactions affect the patient both short- and long-term.

    Immune thrombocytopenia (ITP) is an autoimmune disease that attacks the body’s platelets. It can have a newly diagnosed and persistent component and can occur in both children and adults. This presentation will discuss newly diagnosed and persistent ITP, diagnosis and treatment for children and adults, and long-term effects for patients with persistent ITP, including psychosocial and financial issues. A case example will follow a patient from diagnosis through various treatments over a 20-year span. At the conclusion of this presentation, the infusion nurse should be able to understand the importance of his or her role in administering IV medications as well as how their interactions affect the patient both short- and long-term.

    Learning Outcomes: At the end of this presentation, the participant will be able to:
    • Define immune thrombocytopenia and differentiate between newly diagnosed and persistent disease
    • Describe 3 treatments for immune thrombocytopenia
    • Discuss ways health care workers can be sensitive to patients with life altering diseases and provide support to them

    Theresa Thrower, BSN, RN, CRNI®, OCN®

    Home Health Case Manager, Kaiser Permanente

    Theresa has been a nurse for 42 years in various fields with a primary focus in home Infusion and home health. For the last 22 years she has worked specifically with chronically ill patients as well as patients who have been diagnosed with immune thrombocytopenia.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 14, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • Health Care of the Future: How Nurses Can Fix the Hospital

    Contains 3 Component(s), Includes Credits Recorded On: 06/19/2019

    In this era of rapid change in health care, nurses must become aware of the opportunities available to contribute. By examining not only nursing’s past, but also its future, various methods emerge that add the all-important nursing voice to the evolution of health care. In addition, examining the National Academy of Medicine’s report and update on the Future of Nursing 2030 suggests further opportunities to contribute. Included in this presentation is a discussion of technology as it contributes to advances in care.

    In this era of rapid change in health care, nurses must become aware of the opportunities available to contribute. By examining not only nursing’s past, but also its future, various methods emerge that add the all-important nursing voice to the evolution of health care. In addition, examining the National Academy of Medicine’s report and update on the Future of Nursing 2030 suggests further opportunities to contribute. Included in this presentation is a discussion of technology as it contributes to advances in care.

    Learning Outcomes: At the end of this presentation the participant will be able to:
    • Describe the role of the registered nurse in the future
    • Describe the Institute of Medicine’s recommendations as they pertain to the nurses’ role
    • Understand strategic practices for developing the nursing role

    Adele Webb, PhD, RN, FNAP, FAAN

    Assistant Dean, Capella University

    Adele Webb, PhD, RN, FNAP, FAAN, is an assistant dean at Capella University. Her focus is on international nurse capacity development as it relates to both communicable and non-communicable diseases. She has received extensive funding for her international work and has published her findings in several refereed journals. Adele has contributed to World Health Organization guidelines, testified to the Institute of Medicine, and given testimony to the White House on nursing workforce issues. She continues to collaborate with the WHO as well as the World NCD Congress, and these efforts have helped contribute to improved nurse capacity in health care systems across 43 countries.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 19, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • Short Peripheral Intravenous Access: A Risk/Benefit Analysis

    Contains 3 Component(s), Includes Credits Recorded On: 05/08/2019

    As the most common procedure performed in the acute care setting, insertion of the short peripheral intravenous (IV) catheter is a basic nursing skill. It is, however, far from benign. There is a lack of standardized education and competency assessment in this foundational skill. In addition, a lack of validated assessment tools has hindered accurate evaluation of the patient harm caused by complications such as infiltration, extravasation, phlebitis, and infection. This presentation will provide an overview and respond to audience questions regarding the use of short peripheral IV access and its role in the current standard of practice, the potential complications that arise with use, and strategies to optimize outcomes in the management of short peripheral IV access.

    As the most common procedure performed in the acute care setting, insertion of the short peripheral intravenous (IV) catheter is a basic nursing skill. It is, however, far from benign. There is a lack of standardized education and competency assessment in this foundational skill. In addition, a lack of validated assessment tools has hindered accurate evaluation of the patient harm caused by complications such as infiltration, extravasation, phlebitis, and infection. This presentation will provide an overview and respond to audience questions regarding the use of short peripheral IV access and its role in the current standard of practice, the potential complications that arise with use, and strategies to optimize outcomes in the management of short peripheral IV access.

    Learning Outcomes: At the conclusion of the webinar, the participant will be able to:
    • Identify two complications of short peripheral catheter access that may cause patient harm
    • Describe two evidence-based strategies to optimize outcomes in short peripheral catheter management

    Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN

    Wheaton Franciscan Home Health & Hospice

    Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN, is a clinical nurse specialist at Wheaton Franciscan Home Health and Hospice, a part of Ascension Health at Home. A fellow of the American Academy of Nursing, she has authored several books on infusion therapy, as well as more than 50 journal articles and book chapters. Ms. Gorski is chair of Infusion Nurses Society’s Infusion Therapy Standards of Practice Committee.

    Barb Nickel, APRN-CNS, NP-C, CRNI®, CCRN

    Clinical Nurse Specialist

    Barb Nickel, APRN-CNS, NP-C, CRNI®, CCRN, has extensive experience in the application of evidence-based guidelines relevant to infusion therapy practice. As a clinical nurse specialist, she is actively involved in infusion-related process improvement at the facility and statewide level, regarding topics such as CLABSI prevention, new graduate training, and smart pump drug library standardization. From 2011 to 2016, Ms. Nickel was a member, then chair/lead nurse-planner for INS’ National Council on Education. She was also a reviewer for both the 2011 and the 2016 Infusion Nursing Standards of Practice.

    CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: May 8, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.